Get started
Author

Juan Flores

Leishmaniasis as an opportunistic infection in HIV-infected patients: determinants of relapse and mortality in a collaborative study of 228 episodes in a Mediterreanean region
2005 · F. Pasquau, J. Ena, et al. · European Journal of Clinical Microbiology & Infectious Diseases · 102
Prognosis and Clinical Evaluation of Infection Caused by Rhodococcus equi in HIV-Infected Patientsa
2003 · Manuel Torres-Tortosa, Julio Arrizabalaga, et al. · CHEST Journal · 101
Osteonecrosis in Patients Infected With HIV: Clinical Epidemiology and Natural History in a Large Case Series From Spain
2006 · Félix Gutiérrez, Sergio Padilla, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 54
High quality of life, treatment tolerability, safety and efficacy in HIV patients switching from triple therapy to lopinavir/ritonavir monotherapy: A randomized clinical trial
2018 · Juan Pasquau, Carmen Hidalgo-Tenorio, et al. · PLoS ONE · 41
PDF
Avascular necrosis of the bone in HIV-infected patients: incidence and associated factors
2002 · Félix Gutiérrez, Sergio Padilla, et al. · AIDS · 38
Corticosteroids for COVID‐19 patients requiring oxygen support? Yes, but not for everyone: Effect of corticosteroids on mortality and intensive care unit admission in patients with COVID‐19 according to patients' oxygen requirements
2020 · Cecilia Tortajada, Enrique Colomer, et al. · Journal of Medical Virology · 25
Excision and V–Y plasty reconstruction for giant condyloma acuminatum
2004 · N. Uribe, M. Millan, et al. · Techniques in Coloproctology · 23
Effectiveness and Safety of Abacavir, Lamivudine, and Zidovudine in Antiretroviral Therapy-Naive HIV-Infected Patients: Results From a Large Multicenter Observational Cohort
2006 · Juan Berenguer, María Jesús Pérez-Elías, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 21
Safety of Switching Nevirapine Twice Daily to Nevirapine Once Daily in Virologically Suppressed Patients
2009 · Daniel Podzamczer, Montserrat Olmo, et al. · JAIDS Journal of Acquired Immune Deficiency Syndromes · 19
Effect of simplification from protease inhibitors to boosted atazanavir‐based regimens in real‐life conditions
2010 · R Rubio, O Serrano, et al. · HIV Medicine · 18
PDF
Time from symptoms onset to remdesivir is associated with the risk of ICU admission: a multicentric analyses
2023 · Rodrigo Alonso-Navarro, Margarita Ramírez, et al. · BMC Infectious Diseases · 11
PDF
Impact of an enhanced screening program on the detection of non-AIDS neoplasias in patients with human immunodeficiency virus infection
2021 · M. Masiá, S. Padilla, et al. · Trials · 10
PDF
Prevalence and duration of symptoms among moderate and severe COVID-19 patients 12 months after discharge
2022 · C. Tortajada, A. Navarro, et al. · Internal and Emergency Medicine · 9
PDF
Short-Term Effect of Ritonavir-Boosted Atazanavir in Hepatitis B and/or C Co-infected, Treatment-Experienced HIV Patients
2009 · María Jesús Pérez-Elías, Jose María Gatell, et al. · HIV Clinical Trials · 9
PDF
Early Detection of Cancer and Precancerous Lesions in Persons With HIV Through a Comprehensive Cancer Screening Protocol
2024 · Félix Gutiérrez, Leandro López, et al. · Clinical Infectious Diseases · 8
Interferon β‐1b for patients with moderate to severe COVID‐19 in the inflammatory phase of the disease
2021 · Cecilia Tortajada, Sol Añón, et al. · Journal of Medical Virology · 8
PDF
Abacavir/lamivudine plus darunavir/ritonavir in routine clinical practice: a multicentre experience in antiretroviral therapy-naive and -experienced patients
2014 · D. Podzamczer, A. Imaz, et al. · Journal of Antimicrobial Chemotherapy · 8
Interferon-free therapy for treating hepatitis C virus in difficult-to-treat HIV-coinfected patients
2017 · Carlos Mínguez, Miguel García-Deltoro, et al. · AIDS · 7
Management of giant anal condyloma by wide local excision and anoplasty
2012 · N. Uribe, C. Rueda, et al. · Colorectal Disease · 7
Impacto de la reducción de dosis de estavudina en su perfil de eficacia/seguridad en pacientes con infección por el virus de la inmunodeficiencia humana inmunológica y virológicamente estables
2007 · Enric Pedrol, Teodoro Martín, et al. · Medicina Clínica · 7
A randomized trial comparing the efficacy and tolerability of two HAART strategies at two years in antiretroviral naive patients
2007 · J. Mallolas, J.L. Blanco, et al. · Revista Clínica Española · 6
Recomendaciones españolas sobre el uso adecuado de enfuvirtida
2007 · Esteban Ribera, Santiago Moreno, et al. · Enfermedades Infecciosas y Microbiología Clínica · 6
Health-Related Quality of Life in HIV Patients Switching to Twice-Daily Indinavir/Ritonavir Regimen or Continuing with Three-Times-Daily Indinavir-Based Therapy
2004 · the BestQol study group, Xavier Badía, et al. · Antiviral Therapy · 5
Patients’ Perception and Effectiveness of a Treatment Containing Enfuvirtide When Used in HIV-Infected Patients Without Very Advanced Disease
2008 · F. Pulido, M.A. Del Pozo, et al. · HIV Clinical Trials · 3
PDF
Genotypic tropism testing in proviral DNA to guide maraviroc initiation in aviremic subjects: 48‐week analysis of the PROTEST study
2014 · Federico Garcia, Eva Poveda, et al. · Journal of the International AIDS Society · 2
PDF
Works count: 35
Citation count: 559
H-index: 11
I10-index: 12
Year
Topic
Type